PECAM1 and neoplasm: Consequently, CSNPs-PE demonstrated the anti-angiogenic effect by inhibiting VEGF and CD31, which prevents the interaction between the tumor and its microenvironment and eventually inhibits tumor growth and expansion [58,59].